Browse/search for people

Publication - Professor Clive Orchard

    Consecutive isoproterenol and adenosine treatment confers marked protection against reperfusion injury in adult but not in immature heart

    A role for glycogen

    Citation

    Lewis, M, Szobi, A, Balaska, D, Khaliulin, I, Adameova, A, Griffiths, E, Orchard, CH & Suleiman, MS, 2018, ‘Consecutive isoproterenol and adenosine treatment confers marked protection against reperfusion injury in adult but not in immature heart: A role for glycogen’. International Journal of Molecular Sciences, vol 19.

    Abstract

    Consecutive treatment of adult rat heart with isoproterenol and adenosine (Iso/Aden), known to consecutively activate PKA/PKC signaling, is cardioprotective against ischemia and reperfusion (I/R). Whether this is cardioprotective in an immature heart is unknown. Langendorff–perfused hearts from adult and immature (60 and 14 days old) male Wistar rats were exposed to 30 min ischemia and 120 min reperfusion, with or without prior perfusion with 5 nM Iso for 3 min followed by 30 µM Aden for 5 min. Changes in hemodynamics (developed pressure and coronary flow) and cardiac injury (Lactate Dehydrogenase (LDH) release and infarct size) were measured. Additional hearts were used to measure glycogen content. Iso induced a similar inotropic response in both age groups. Treatment with Iso/Aden resulted in a significant reduction in time to the onset of ischemic contracture in both age groups whilst time to peak contracture was significantly shorter only in immature hearts. Upon reperfusion, the intervention reduced cardiac injury and functional impairment in adults with no protection of immature heart. Immature hearts have significantly less glycogen content compared to adult. This work shows that Iso/Aden perfusion confers protection in an adult heart but not in an immature heart. It is likely that metabolic differences including glycogen content contribute to this difference.

    Full details in the University publications repository